Hussman Strategic Advisors’s Elevance Health ELV Stock Holding History

Hussman Strategic Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,100	Closed	-$775K	–	267
2024 Q4	$775K	Buy	+2,100	New	+$879K	0.23%	155
2015 Q3	–	Sell	-50,000	Closed	-$8.21M	–	219
2015 Q2	$8.21M	Hold	50,000	–	–	0.95%	44
2015 Q1	$7.72M	Hold	50,000	–	–	0.81%	47
2014 Q4	$6.28M	Sell	50,000 -50,000	-50%	-$6.18M	0.62%	69
2014 Q3	$12M	Sell	100,000 -100,000	-50%	-$11.5M	1.02%	27
2014 Q2	$21.5M	Buy	+200,000	New	+$20.6M	1.65%	3
2014 Q1	–	Sell	-150,000	Closed	-$13.9M	–	203
2013 Q4	$13.9M	Hold	150,000	–	–	0.99%	41
2013 Q3	$12.5M	Buy	+150,000	New	+$12.9M	0.69%	71

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hussman Strategic Advisors's ELV Position: Q1 2025 in Review

Hussman Strategic Advisors sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 2,100 shares — an estimated $775K sold.

Hussman Strategic Advisors first reported a position in ELV in Q3 2013 and held it in 8 quarters. The position peaked at $21.5M in Q2 2014. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Hussman Strategic Advisors reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Hussman Strategic Advisors sold 2,100 Elevance Health shares in Q1 2025, an estimated $775K.
Hussman Strategic Advisors first reported a position in Elevance Health in Q3 2013 and held it in 8 quarters.
Hussman Strategic Advisors's Elevance Health position peaked at $21.5M in Q2 2014.
1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Hussman Strategic Advisors's 13F filing for Q1 2025, filed 5 May 2025.